OncoGenex Pharmaceuticals Inc (OGXI.OQ) Analyst Research| Reuters.com
Edition:
United States

OncoGenex Pharmaceuticals Inc (OGXI.OQ)

OGXI.OQ on NASDAQ Stock Exchange Capital Market

1.00USD
28 Jun 2016
Change (% chg)

$0.05 (+4.95%)
Prev Close
$0.95
Open
$1.00
Day's High
$1.00
Day's Low
$0.97
Volume
5,927
Avg. Vol
47,815
52-wk High
$4.09
52-wk Low
$0.46

Reports per page
Select Report Title Date Provider Pgs Price
Thomson Reuters Stock Report - OncoGenex Pharmaceuticals Inc (OGXI-O) 28 Jun 2016 Thomson Reuters Stock Report 12 25.00
Wright Investors Service Comprehensive Report for Oncogenex Pharmaceuticals, Incorporation 27 Jun 2016 Wright Reports 61 75.00
OGXI: Due Diligence Review: Forensic Earnings and Valuation 27 Jun 2016 New Constructs, LLC 10 25.00
ValuEngine Rating and Forecast Report for OGXI 25 Jun 2016 ValuEngine, Inc. 11 25.00
OncoGenex Pharmaceuticals 25 Jun 2016 S&P Capital IQ Quantitative Report 9 104.00
ONCOGENEX PHARMACEUTICALS INC (OGXI=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS 24 Jun 2016 Pechala's Reports 2 25.00
OncoGenex Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 24 Jun 2016 Reuters Investment Profile 12 20.00
Value Graph: ONCOGENEX PHARM -- OGXI 23 Jun 2016 Ford Investor Services, Inc. 1 12.00
 
Name Age Since Current Position

Jack Goldstein

68 2010 Independent Chairman of the Board

Scott Cormack

49 2013 President, Chief Executive Officer, Treasurer, Secretary, Director

John Bencich

38 2014 Chief Financial Officer, Vice President

Cindy Jacobs

57 2008 Executive Vice President, Chief Medical Officer

Neil Clendeninn

66 2008 Independent Director